Maximilian Diehn, Ph.D. - Publications

Affiliations: 
2004 Stanford University, Palo Alto, CA 
Area:
gene expression

107 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttmann A, Casasnovas O, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, ... ... Diehn M, et al. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. PMID 31280963 DOI: 10.1016/j.cell.2019.06.011  0.8
2019 Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology. PMID 31061481 DOI: 10.1038/s41587-019-0114-2  0.8
2019 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, ... ... Diehn M, et al. Reply to J. Wang et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801907. PMID 30753108 DOI: 10.1200/JCO.18.01907  0.8
2018 Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, Trivedi D, Chabon JJ, Chaudhuri AA, Stehr H, Liu CL, Lim H, Costa HA, Nabet BY, Sin MLY, ... ... Diehn M, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discovery. PMID 30578357 DOI: 10.1158/2159-8290.CD-18-0825  0.8
2018 Reid S, Newman AM, Diehn M, Alizadeh AA, Tibshirani R. Genomic Feature Selection by Coverage Design Optimization. Journal of Applied Statistics. 45: 2658-2676. PMID 30294060 DOI: 10.1080/02664763.2018.1432577  0.8
2018 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, ... ... Diehn M, et al. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785246. PMID 30125215 DOI: 10.1200/JCO.2018.78.5246  0.8
2018 Przybyl J, Chabon JJ, Spans L, Ganjoo K, Vennam S, Newman AM, Forgó E, Varma S, Zhu S, Debiec-Rychter M, Alizadeh AA, Diehn M, van de Rijn M. Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29463554 DOI: 10.1158/1078-0432.CCR-17-3704  0.8
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, ... ... Diehn M, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. PMID 28899864 DOI: 10.1158/2159-8290.CD-17-0716  0.8
2017 Newman AM, Gentles AJ, Liu CL, Diehn M, Alizadeh AA. Data normalization considerations for digital tumor dissection. Genome Biology. 18: 128. PMID 28679399 DOI: 10.1186/s13059-017-1257-4  0.8
2017 Scherer F, Kurtz DM, Diehn M, Alizadeh AA. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood. PMID 28600337 DOI: 10.1182/blood-2017-03-735639  0.8
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, ... ... Diehn M, et al. Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 13513. PMID 27841271 DOI: 10.1038/ncomms13513  0.8
2016 Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, ... ... Diehn M, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Science Translational Medicine. 8: 364ra155. PMID 27831904 DOI: 10.1126/scitranslmed.aai8545  0.8
2016 Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, ... ... Diehn M, et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. PMID 27663899 DOI: 10.1158/2159-8290.CD-16-0127  0.8
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, ... ... Diehn M, et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 11815. PMID 27283993 DOI: 10.1038/ncomms11815  0.8
2016 Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, ... ... Diehn M, et al. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27267049 DOI: 10.1016/j.radonc.2016.05.007  0.8
2016 Wu J, Gensheimer MF, Dong X, Rubin DL, Napel S, Diehn M, Loo BW, Li R. Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics. PMID 27212196 DOI: 10.1016/j.ijrobp.2016.03.018  0.8
2016 Wu J, Aguilera T, Shultz D, Gudur M, Rubin DL, Loo BW, Diehn M, Li R. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology. 151829. PMID 27046074 DOI: 10.1148/radiol.2016151829  0.8
2016 Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, ... ... Diehn M, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nature Biotechnology. PMID 27018799 DOI: 10.1038/nbt.3520  0.8
2016 Binkley MS, Shrager JB, Chaudhuri A, Popat R, Maxim PG, Shultz DB, Diehn M, Loo BW. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. Radiation Oncology (London, England). 11: 40. PMID 26975700 DOI: 10.1186/s13014-016-0616-8  0.8
2015 Binkley MS, Hiniker SM, Chaudhuri A, Maxim PG, Diehn M, Loo BW, Shultz DB. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. International Journal of Radiation Oncology, Biology, Physics. PMID 26831903 DOI: 10.1016/j.ijrobp.2015.12.007  0.8
2015 Myall NJ, Neal JW, Cho-Phan CD, Zhou LY, Stehr H, Zhou L, Diehn M, Wakelee HA. Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene. Clinical Lung Cancer. PMID 26776917 DOI: 10.1016/j.cllc.2015.12.001  0.8
2015 Cirujeda P, Muller H, Rubin D, Aguilera TA, Loo BW, Diehn M, Binefa X, Depeursinge A. 3D Riesz-wavelet based Covariance descriptors for texture classification of lung nodule tissue in CT. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2015: 7909-12. PMID 26738126 DOI: 10.1109/EMBC.2015.7320226  0.8
2015 Sun JG, Chen XW, Zhang LP, Wang J, Diehn M. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling. Oncotarget. PMID 26695440 DOI: 10.18632/oncotarget.6655  0.8
2015 Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in Radiation Oncology. 25: 305-12. PMID 26384278 DOI: 10.1016/j.semradonc.2015.05.001  0.8
2015 Gentles AJ, Bratman SV, Lee LJ, Harris JP, Feng W, Nair RV, Shultz DB, Nair VS, Hoang CD, West RB, Plevritis SK, Alizadeh AA, Diehn M. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute. 107. PMID 26286589 DOI: 10.1093/jnci/djv211  0.8
2015 Westover KD, Loo BW, Gerber DE, Iyengar P, Choy H, Diehn M, Hughes R, Schiller J, Dowell J, Wardak Z, Sher D, Christie A, Xie XJ, Corona I, Sharma A, et al. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. International Journal of Radiation Oncology, Biology, Physics. 93: 72-81. PMID 26279026 DOI: 10.1016/j.ijrobp.2015.05.004  0.8
2015 Yu AS, von Eyben R, Yamamoto T, Diehn M, Shultz DB, Loo BW, Maxim PG. Anatomic optimization of lung tumor stereotactic ablative radiation therapy. Practical Radiation Oncology. PMID 26231596 DOI: 10.1016/j.prro.2015.05.008  0.8
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature Medicine. 21: 938-45. PMID 26193342 DOI: 10.1038/nm.3909  0.8
2015 Binkley MS, Trakul N, Jacobs LR, von Eyben R, Le QT, Maxim PG, Loo BW, Shultz DB, Diehn M. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 26025776 DOI: 10.1016/j.ijrobp.2015.04.004  0.8
2015 Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer (Amsterdam, Netherlands). 89: 50-6. PMID 25997421 DOI: 10.1016/j.lungcan.2015.04.014  0.8
2015 King MT, Maxim PG, Diehn M, Loo BW, Xing L. Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 92: 683-90. PMID 25936813 DOI: 10.1016/j.ijrobp.2015.02.037  0.8
2015 Jeong Y, Swami S, Krishnan AV, Williams JD, Martin S, Horst RL, Albertelli MA, Feldman BJ, Feldman D, Diehn M. Inhibition of Mouse Breast Tumor Initiating Cells by Calcitriol and Dietary Vitamin D. Molecular Cancer Therapeutics. PMID 25934710 DOI: 10.1158/1535-7163.MCT-15-0066  0.8
2015 Jeong Y, Rhee H, Martin S, Klass D, Lin Y, Nguyen LX, Feng W, Diehn M. Identification and genetic manipulation of human and mouse oesophageal stem cells. Gut. PMID 25897018 DOI: 10.1136/gutjnl-2014-308491  0.8
2015 Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, ... ... Diehn M, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 125: 3679-87. PMID 25887775 DOI: 10.1182/blood-2015-03-635169  0.8
2015 Negahdar M, Fasola CE, Yu AS, von Eyben R, Yamamoto T, Diehn M, Fleischmann D, Tian L, Loo BW, Maxim PG. Noninvasive pulmonary nodule elastometry by CT and deformable image registration. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 115: 35-40. PMID 25824979 DOI: 10.1016/j.radonc.2015.03.015  0.8
2015 Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods. 12: 453-7. PMID 25822800 DOI: 10.1038/nmeth.3337  0.8
2015 Bratman SV, Newman AM, Alizadeh AA, Diehn M. Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq. Expert Review of Molecular Diagnostics. 15: 715-9. PMID 25773944 DOI: 10.1586/14737159.2015.1019476  0.8
2015 Shultz DB, Diehn M, Loo BW. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer. Seminars in Radiation Oncology. 25: 78-86. PMID 25771411 DOI: 10.1016/j.semradonc.2014.11.005  0.8
2015 Yom SS, Diehn M, Raben D. Molecular determinants of radiation response in non-small cell lung cancer. Seminars in Radiation Oncology. 25: 67-77. PMID 25771410 DOI: 10.1016/j.semradonc.2014.12.007  0.8
2015 Harris JP, Chang-Halpenny CN, Maxim PG, Quon A, Graves EE, Diehn M, Loo BW. Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. Clinical Lung Cancer. PMID 25770888 DOI: 10.1016/j.cllc.2015.01.007  0.8
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers Nature Medicine. 21: 938-945. DOI: 10.1038/nm.3909  0.8
2015 Chaudhuri AA, Binkley MS, Diehn M. Cancer stem cells and tumor radioresistance Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. 519-531. DOI: 10.1007/978-3-319-21030-8_18  0.8
2014 Kuo P, Bratman SV, Shultz DB, von Eyben R, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia AJ, Koong AC, Diehn M, Le QT. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5558-69. PMID 25189484 DOI: 10.1158/1078-0432.CCR-14-1138  0.8
2014 Newman AM, Bratman SV, Stehr H, Lee LJ, Liu CL, Diehn M, Alizadeh AA. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics (Oxford, England). 30: 3390-3. PMID 25143292 DOI: 10.1093/bioinformatics/btu549  0.8
2014 Yamamoto T, Kabus S, Lorenz C, Mittra E, Hong JC, Chung M, Eclov N, To J, Diehn M, Loo BW, Keall PJ. Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images. International Journal of Radiation Oncology, Biology, Physics. 90: 414-22. PMID 25104070 DOI: 10.1016/j.ijrobp.2014.06.006  0.8
2014 Xiao N, Lin Y, Cao H, Sirjani D, Giaccia AJ, Koong AC, Kong CS, Diehn M, Le QT. Neurotrophic factor GDNF promotes survival of salivary stem cells. The Journal of Clinical Investigation. 124: 3364-77. PMID 25036711 DOI: 10.1172/JCI74096  0.8
2014 Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. International Journal of Radiation Oncology, Biology, Physics. 90: 216-23. PMID 25015205 DOI: 10.1016/j.ijrobp.2014.05.025  0.8
2014 Shultz DB, Trakul N, Maxim PG, Diehn M, Loo BW. Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. Practical Radiation Oncology. 4: 272-8. PMID 25012837 DOI: 10.1016/j.prro.2013.08.005  0.8
2014 Moré JM, Eclov NC, Chung MP, Wynne JF, Shorter JH, Nelson DD, Hanlon AL, Burmeister R, Banos P, Maxim PG, Loo BW, Diehn M. Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 957-64. PMID 24926543 DOI: 10.1097/JTO.0000000000000182  0.8
2014 Shultz DB, Jang SS, Hanlon AL, Diehn M, Loo BW, Maxim PG. The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. Practical Radiation Oncology. 4: 192-7. PMID 24766687 DOI: 10.1016/j.prro.2013.07.010  0.8
2014 Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature Medicine. 20: 548-54. PMID 24705333 DOI: 10.1038/nm.3519  0.8
2014 Shultz DB, Trakul N, Abelson JA, Murphy JD, Maxim PG, Le QT, Loo BW, Diehn M. Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clinical Lung Cancer. 15: 294-301.e3. PMID 24594400 DOI: 10.1016/j.cllc.2013.12.011  0.8
2014 Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, Cai S, Scheeren FA, Kuo AH, Diehn M. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells (Dayton, Ohio). 32: 1734-45. PMID 24497069 DOI: 10.1002/stem.1662  0.8
2014 Harris JP, Murphy JD, Hanlon AL, Le QT, Loo BW, Diehn M. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 88: 872-84. PMID 24495591 DOI: 10.1016/j.ijrobp.2013.12.010  0.8
2014 Zhou B, Damrauer JS, Bailey ST, Hadzic T, Jeong Y, Clark K, Fan C, Murphy L, Lee CY, Troester MA, Miller CR, Jin J, Darr D, Perou CM, Levine RL, ... Diehn M, et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. The Journal of Clinical Investigation. 124: 553-63. PMID 24435044 DOI: 10.1172/JCI69804  0.8
2014 Lee CY, Lin Y, Bratman SV, Feng W, Kuo AH, Scheeren FA, Engreitz JM, Varma S, West RB, Diehn M. Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation. Cancer Research. 74: 341-52. PMID 24177178 DOI: 10.1158/0008-5472.CAN-13-1055  0.8
2014 Jamshidi N, Diehn M, Bredel M, Kuo MD. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology. 270: 1-2. PMID 24056404 DOI: 10.1148/radiol.13130078  0.8
2014 Bratman SV, Diehn M. Lung Cancer Stem Cells and Resistance to Radiotherapy Cancer Stem Cells. 171-182. DOI: 10.1002/9781118356203.ch13  0.8
2013 Liu MB, Eclov NC, Trakul N, Murphy J, Diehn M, Le QT, Dieterich S, Maxim PG, Loo BW. Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Practical Radiation Oncology. 3: 294-300. PMID 24674401 DOI: 10.1016/j.prro.2012.09.003  0.8
2013 Li R, Han B, Meng B, Maxim PG, Xing L, Koong AC, Diehn M, Loo BW. Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 87: 917-23. PMID 24113060 DOI: 10.1016/j.ijrobp.2013.08.015  0.8
2013 Yamamoto T, Kabus S, Lorenz C, Johnston E, Maxim PG, Diehn M, Eclov N, Barquero C, Loo BW, Keall PJ. 4D CT lung ventilation images are affected by the 4D CT sorting method. Medical Physics. 40: 101907. PMID 24089909 DOI: 10.1118/1.4820538  0.8
2013 Hong JC, Eclov NC, Yu Y, Rao AK, Dieterich S, Le QT, Diehn M, Sze DY, Loo BW, Kothary N, Maxim PG. Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 14: 4046. PMID 23470933  0.8
2013 Dalerba P, Clarke MF, Weissman IL, Diehn M. Stem Cells, Cell Differentiation, and Cancer Abeloff's Clinical Oncology: Fifth Edition. 98-107.e5. DOI: 10.1016/B978-1-4557-2865-7.00007-2  0.8
2013 Shultz DB, Grecula JC, Hayman J, Diehn M, Loo BW. The optimal use of radiotherapy in small cell lung cancer Jnccn Journal of the National Comprehensive Cancer Network. 11: 107-114.  0.8
2012 Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer (Amsterdam, Netherlands). 78: 219-24. PMID 23009727 DOI: 10.1016/j.lungcan.2012.08.016  0.8
2012 Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo BW, Diehn M. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1462-5. PMID 22895143 DOI: 10.1097/JTO.0b013e31825f22ce  0.8
2012 Li R, Mok E, Chang DT, Daly M, Loo BW, Diehn M, Le QT, Koong A, Xing L. Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images. International Journal of Radiation Oncology, Biology, Physics. 83: e709-15. PMID 22554582 DOI: 10.1016/j.ijrobp.2012.03.006  0.8
2012 Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, ... ... Diehn M, et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. International Journal of Radiation Oncology, Biology, Physics. 84: 231-7. PMID 22381907 DOI: 10.1016/j.ijrobp.2011.10.071  0.8
2011 Terezakis SA, Heron DE, Lavigne RF, Diehn M, Loo BW. What the diagnostic radiologist needs to know about radiation oncology. Radiology. 261: 30-44. PMID 21931140 DOI: 10.1148/radiol.11101688  0.8
2011 Johnston E, Diehn M, Murphy JD, Loo BW, Maxim PG. Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. Medical Physics. 38: 2424-9. PMID 21776777 DOI: 10.1118/1.3577601  0.8
2011 Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, et al. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 920-6. PMID 21774104 DOI: 10.1097/JTO.0b013e31821517db  0.8
2011 Hong JC, Yu Y, Rao AK, Dieterich S, Maxim PG, Le QT, Diehn M, Sze DY, Kothary N, Loo BW. High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. International Journal of Radiation Oncology, Biology, Physics. 81: 85-90. PMID 20675070 DOI: 10.1016/j.ijrobp.2010.04.037  0.8
2011 Brown M, Loo BW, Diehn M, Carlson DJ. In reply to Song et al. International Journal of Radiation Oncology Biology Physics. 81: 1194. DOI: 10.1016/j.ijrobp.2011.05.023  0.8
2011 Brown M, Loo B, Diehn M, Carlson D. Influence of tumor hypoxia on Stereotactic Ablative Radiotherapy (SABR): Response to Drs. Meyer and Timmerman International Journal of Radiation Oncology Biology Physics. 79: 1600. DOI: 10.1016/j.ijrobp.2010.11.013  0.8
2010 Rothenberg ME, Clarke MF, Diehn M. The Myc connection: ES cells and cancer. Cell. 143: 184-6. PMID 20946977 DOI: 10.1016/j.cell.2010.09.046  0.8
2010 Brown JM, Diehn M, Loo BW. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. International Journal of Radiation Oncology, Biology, Physics. 78: 323-7. PMID 20832663 DOI: 10.1016/j.ijrobp.2010.04.070  0.8
2010 Diehn M, Majeti R. Metastatic cancer stem cells: an opportunity for improving cancer treatment? Cell Stem Cell. 6: 502-3. PMID 20569685 DOI: 10.1016/j.stem.2010.05.001  0.8
2009 Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 14016-21. PMID 19666525 DOI: 10.1073/pnas.0906549106  0.8
2009 Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K, Clarke MF. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 138: 592-603. PMID 19665978 DOI: 10.1016/j.cell.2009.07.011  0.8
2009 Diehn M, Cho RW, Clarke MF. Therapeutic implications of the cancer stem cell hypothesis. Seminars in Radiation Oncology. 19: 78-86. PMID 19249645 DOI: 10.1016/j.semradonc.2008.11.002  0.8
2009 Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 458: 780-3. PMID 19194462 DOI: 10.1038/nature07733  0.8
2008 Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, Aldape K, Cha S, Kuo MD. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proceedings of the National Academy of Sciences of the United States of America. 105: 5213-8. PMID 18362333 DOI: 10.1073/pnas.0801279105  0.8
2008 Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells (Dayton, Ohio). 26: 364-71. PMID 17975224 DOI: 10.1634/stemcells.2007-0440  0.8
2008 Liang Y, Diehn M, Bollen AW, Israel MA, Gupta N. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. Journal of Neuro-Oncology. 86: 133-41. PMID 17653508 DOI: 10.1007/s11060-007-9457-5  0.8
2006 Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. Journal of the National Cancer Institute. 98: 1755-7. PMID 17179471 DOI: 10.1093/jnci/djj505  0.8
2006 Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. Bmc Genomics. 7: 115. PMID 16704732 DOI: 10.1186/1471-2164-7-115  0.8
2006 Diehn M, Bhattacharya R, Botstein D, Brown PO. Genome-scale identification of membrane-associated human mRNAs. Plos Genetics. 2: e11. PMID 16415983 DOI: 10.1371/journal.pgen.0020011  0.8
2005 Diehn JJ, Diehn M, Marmor MF, Brown PO. Differential gene expression in anatomical compartments of the human eye. Genome Biology. 6: R74. PMID 16168081 DOI: 10.1186/gb-2005-6-9-r74  0.8
2005 Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America. 102: 5814-9. PMID 15827123 DOI: 10.1073/pnas.0402870102  0.8
2004 Tu IP, Schaner M, Diehn M, Sikic BI, Brown PO, Botstein D, Fero MJ. A method for detecting and correcting feature misidentification on expression microarrays. Bmc Genomics. 5: 64. PMID 15357875 DOI: 10.1186/1471-2164-5-64  0.8
2004 Piedras-Rentería ES, Pyle JL, Diehn M, Glickfeld LL, Harata NC, Cao Y, Kavalali ET, Brown PO, Tsien RW. Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. Proceedings of the National Academy of Sciences of the United States of America. 101: 3609-14. PMID 14990796 DOI: 10.1073/pnas.0308188100  0.8
2003 Roose JP, Diehn M, Tomlinson MG, Lin J, Alizadeh AA, Botstein D, Brown PO, Weiss A. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. Plos Biology. 1: E53. PMID 14624253 DOI: 10.1371/journal.pbio.0000053  0.8
2003 Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, et al. Gene expression patterns in ovarian carcinomas. Molecular Biology of the Cell. 14: 4376-86. PMID 12960427 DOI: 10.1091/mbc.E03-05-0279  0.8
2003 Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proceedings of the National Academy of Sciences of the United States of America. 100: 1896-901. PMID 12578971 DOI: 10.1073/pnas.252784499  0.8
2003 Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Research. 31: 219-23. PMID 12519986 DOI: 10.1093/nar/gkg014  0.8
2002 Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 99: 11796-801. PMID 12195013 DOI: 10.1073/pnas.092284399  0.8
2002 DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biology. 3: RESEARCH0032. PMID 12184806  0.8
2002 Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. Bmc Immunology. 3: 5. PMID 12079505  0.8
2002 Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 99: 8886-91. PMID 12077300 DOI: 10.1073/pnas.132253599  0.8
2002 Clément K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, Langin D. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Research. 12: 281-91. PMID 11827947 DOI: 10.1101/gr.207702  0.8
2002 Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proceedings of the National Academy of Sciences of the United States of America. 99: 972-7. PMID 11805339 DOI: 10.1073/pnas.231625398  0.8
2002 Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. Transcriptional response of human mast cells stimulated via the Fcε RI and identification of mast cells as a source of IL-11 Bmc Immunology. 3. DOI: 10.1186/1471-2172-3-5  0.8
2001 Diehn M, Relman DA. Comparing functional genomic datasets: lessons from DNA microarray analyses of host-pathogen interactions. Current Opinion in Microbiology. 4: 95-101. PMID 11173041 DOI: 10.1016/S1369-5274(00)00171-5  0.8
2000 Casagrande R, Stern P, Diehn M, Shamu C, Osario M, Zúñiga M, Brown PO, Ploegh H. Degradation of proteins from the ER of S. cerevisiae requires an intact unfolded protein response pathway. Molecular Cell. 5: 729-35. PMID 10882108  0.8
2000 Diehn M, Alizadeh AA, Brown PO. Examining the living genome in health and disease with DNA microarrays. Jama. 283: 2298-9. PMID 10807394  0.8
2000 Diehn M, Eisen MB, Botstein D, Brown PO. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. Nature Genetics. 25: 58-62. PMID 10802657 DOI: 10.1038/75603  0.8
2000 Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. The Journal of Biological Chemistry. 275: 2219-30. PMID 10636929 DOI: 10.1074/jbc.275.3.2219  0.8
Show low-probability matches.